Animation - Understanding Immunotherapy for NSCLC with PD-1 and PD-L1 Biomarkers

Slide Show - Understanding Immunotherapy for NSCLC with PD-1 and PD-L1 Biomarkers

Expert Videos

1. What is immunotherapy and how does it work for lung cancer?

2. What types of immunotherapy are used to treat lung cancer?

3. What side effects can be associated with immunotherapy for lung cancer?

4. What is comprehensive biomarker testing for lung cancer? What do I need to know?

Expert Video - What side effects can be associated with immunotherapy for lung cancer?

Lung cancer expert Dr. Joseph Leach of Allina Health Cancer Institute shares an overview of the side effects that may be associated with immunotherapy for lung cancer. He explains that some people experience very few side effects, while others have more serious complications and discusses some examples. It is important to let your doctor know right away about any side effects you experience. Your doctor can help you get them under control quickly.

Click here to take our SURVEY
Your feedback is important to us! We will use your feedback to develop future areas of content about lung cancer which will help other patients, caregivers and families.

Section: Immunotherapy for NSCLC with PD-1 and PD-L1 Biomarkers

Animation - Understanding Immunotherapy for NSCLC with PD-1 and PD-L1 Biomarkers

Slide Show - Understanding Immunotherapy for NSCLC with PD-1 and PD-L1 Biomarkers

Expert Videos

1. What is immunotherapy and how does it work for lung cancer?

2. What types of immunotherapy are used to treat lung cancer?

3. What side effects can be associated with immunotherapy for lung cancer?

4. What is comprehensive biomarker testing for lung cancer? What do I need to know?

Other Modules:

NSCLC Treatment When You Have an EGFR Mutation

NSCLC Treatment Options When You Have an EGFR Mutation

NSCLC Treatment When You Have a KRAS Mutation

NSCLC Treatment Options When You Have a KRAS Mutation

NSCLC Treatment for Less Common Mutations: ALK, BRAF, ROS1, HER2, MET

Understanding Non-Small Cell Lung Cancer (NSCLC)

Understanding Small Cell Lung Cancer (SCLC)

Screening for Lung Cancer

Lung Cancer Screening for Black Americans

Lung Cancer Screening for Native Americans

Diagnosis and Screening of Lung Cancer

Staging of Lung Cancer

Understanding Biomarker Testing in Non-Small Cell Lung Cancer

Treatment and Management of Lung Cancer

Immunotherapy for Lung Cancer

Targeted Therapy in Non-Small Cell Lung Cancer

Understanding Clinical Trials in Lung Cancer

Lung Cancer Clinical Trials and the US Black Community

Lung Cancer Clinical Trials and Native Americans

Understanding Prehabilitation for Lung Cancer Surgery

Your Prehabilitation Plan for Lung Cancer Surgery

Patient Stories:

Mr. Satterfield's Story

Sharon’s Story

Terri's Story

Tricia's Story

This educational activity has been developed by A Breath of Hope Lung Foundation and Mechanisms in Medicine Inc.

This activity is supported by educational grants from AstraZeneca Pharmaceuticals, Bristol-Myers Squibb Foundation Inc., Bristol-Myers Squibb Grants and Giving, Foundation Medicine, Genentech, Jazz Pharmaceuticals, Merck Sharp & Dohme LLC, Neogenomics, Novartis, Pfizer, and Takeda Oncology.

This website is part of the Animated Patient^® series developed by Mechanisms in Medicine Inc., to provide highly visual formats of learning for patients to improve their understanding, make informed shared decisions, and partner with their healthcare professionals for optimal outcomes.